AMLP News 19.20 08/29/2014 04:31:13 Alps Alerian MLP ETF (AM

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alps Alerian MLP ETF (AMLP) 19.20 $AMLP

ALPS Alerian MLP ETF Up 12.6% Since SmarTrend Uptrend Call (AMLP)
Comtex SmarTrend(R) - Wed Aug 27, 9:29AM CDT
SmarTrend identified an Uptrend for ALPS Alerian MLP ETF (NYSE:AMLP) on January 22nd, 2013 at $16.99. In approximately 19 months, ALPS Alerian MLP ETF has returned 12.63% as of today's recent price of $19.13.

Shares of AMLP Up 11.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Aug 19, 5:15PM CDT
SmarTrend identified an Uptrend for ALPS Alerian MLP ETF (NYSE:AMLP) on January 22nd, 2013 at $16.99. In approximately 19 months, ALPS Alerian MLP ETF has returned 11.75% as of today's recent price of $18.98.

Viper Energy Can Make You Profits But Can Also Bite
at The Street - Mon Aug 18, 10:22AM CDT
The mineral rights vehicle offers a new business opportunity but is not without risks.

MLP ETF Hits the Market Targeting Yield Growth - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 7:01AM CDT
The latest product to hit the market in the MLP space focuses in on distribution growth.

MLP ETFs Soar on Kinder Morgan Consolidation Plan - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Aug 12, 12:00PM CDT
Kinder Morgan consolidation plan spreads optimism into the entire MLP sector, driving the ETFs higher.

ALPS Alerian MLP ETF Shares Up 9.7% Since SmarTrend's Buy Recommendation (AMLP)
Comtex SmarTrend(R) - Tue Aug 12, 11:18AM CDT
SmarTrend identified an Uptrend for ALPS Alerian MLP ETF (NYSE:AMLP) on January 22nd, 2013 at $16.99. In approximately 19 months, ALPS Alerian MLP ETF has returned 9.66% as of today's recent price of $18.63.

'Fast Money' Recap: Can You Trust This Rally?
at The Street - Tue Aug 12, 4:00AM CDT
The trading panel discussed whether the Federal Reserve is having more of an effect on the markets than geopolitical events.

After Yesterday's Rally of 3.03% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Aug 11, 4:29PM CDT
ALPS Alerian MLP ETF (NYSE:AMLP) traded in a range yesterday that spanned from a low of $18.61 to a high of $18.83. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $18.22 on volume of 6.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Alerian MLP ETF (NYSE: AMLP) Declares Third Quarter Distribution of $0.2840
Business Wire - Wed Aug 06, 8:30AM CDT
The Alerian MLP ETF (Master Limited Partnership Exchange-Traded Fund) declared its third quarter 2014 distribution of $0.2840 on Tuesday August 5th. The dividend is payable on August 13, 2014 to shareholders of record on August 8, 2014.

Shares of AMLP Up 9.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Aug 05, 10:05AM CDT
SmarTrend identified an Uptrend for ALPS Alerian MLP ETF (NYSE:AMLP) on January 22nd, 2013 at $16.99. In approximately 19 months, ALPS Alerian MLP ETF has returned 9.57% as of today's recent price of $18.61.

ALPS Alerian MLP ETF Has Returned 11.6% Since SmarTrend Recommendation (AMLP)
Comtex SmarTrend(R) - Fri Jul 25, 11:17AM CDT
SmarTrend identified an Uptrend for ALPS Alerian MLP ETF (NYSE:AMLP) on January 22nd, 2013 at $16.99. In approximately 18 months, ALPS Alerian MLP ETF has returned 11.63% as of today's recent price of $18.96.

Zacks Investment Ideas feature highlights: Alerian MLP ETF, JPMorgan Alerian MLP Index ETN, UBS ETRACS Alerian MLP Infrastructure ETN and Credit Suisse Cushing 30 MLP Index ETN
PR Newswire - Mon Jul 21, 8:30AM CDT
Today, Zacks Investment Ideas feature highlights Features: Alerian MLP ETF (AMEX:AMLP-Free Report), JPMorgan Alerian MLP Index ETN (AMEX:AMJ-Free Report), UBS ETRACS Alerian MLP Infrastructure ETN (AMEX:MLPI-Free Report) and Credit Suisse Cushing 30 MLP Index ETN (AMEX:MLPN-Free Report).

3 MLP ETFs for Excellent Income and Growth - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Fri Jul 18, 10:44AM CDT
With their outsized yields and solid growth potential, the popularity of MLPs continues to surge.

Uptrend Call Working As ALPS Alerian MLP ETF Stock Rises 11.5% (AMLP)
Comtex SmarTrend(R) - Fri Jul 18, 10:05AM CDT
SmarTrend identified an Uptrend for ALPS Alerian MLP ETF (NYSE:AMLP) on January 22nd, 2013 at $16.99. In approximately 18 months, ALPS Alerian MLP ETF has returned 11.45% as of today's recent price of $18.93.

Forget Interest Rates, MLPs Will Continue to Make You Money
Joseph Hogue, The Motley Fool - Motley Fool - Mon Jul 14, 2:47PM CDT
Even minutes from the most recent meeting of the Federal Open Market Committee, signaling an October end to bond purchases, were not enough to move treasury rates out of their funk. Yields have hovered around 2.5% for two months and are down...

Leveraged ETF Launch: Non Energy MLP ETN Hits Market - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Jul 04, 3:01PM CDT
ETRACS is expanding its product lineup with a leveraged version of its ex Energy MLP ETN.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Yangtze River Cultural Revival: Nanjing's Bold Vision

Updated Category News Views 42

Nanjing Hosts Cultural Dialogue on the Yangtze Right in the heart of Nanjing, there's been a buzz about preserving the past while facing the future head-on. Picture this: intellectual heavyweights from around the Yangtze basin gathering not in some plush conference room, but on the river itself. On November 10, 2026, the meeting of minds set sail, departing from Zhongshan...

Continue Reading
Historic Ted Williams Baseball Goes Up for Auction

Updated Category News Views 155

When they say history's for sale, I guess they weren't kidding, were they? Here's a gem from the annals of baseball that might just light up your investment senses—the first Ted Williams-signed baseball from his early days with the Boston Red Sox in 1937 is up for auction. If you're a collector, or even just a baseball romantic, this one's hard to ignore. A Piece of...

Continue Reading
What's at Stake: Pearl Diver's Q3 2026 Earnings Call

Updated Category News Views 60

Upcoming Unveiling: Pearl Diver's Latest Financials Heads up, folks. November 16 can't come soon enough for those keeping tabs on Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA). The bigwigs over there are planning to spill the beans on their third quarter 2026 financial results. They'll kick things off before the market even has its first cup of java on Monday morning...

Continue Reading
Dutch Bros Launches 'Passenger Princess' Event with New Drink

Updated Category News Views 126

Frothy Celebrations for Passenger Princesses There's a fresh hue tinkling across the drive-thru circuit this November, dipped in audacity and powered by social trend winds. Dutch Bros, that lively drive-thru kingpin, is capitalizing on a viral TikTok trend by rolling out the pink carpet for its third annual National Passenger Princess Day. And this ain't just a one-day...

Continue Reading
Southfield Capital Exits TFS to AEA Investors

Updated Category News Views 87

A Breakthrough Carve-Out Success Story A story that starts with a carve-out and winds up with a strategic sale reeks of experience, and that's precisely what Southfield Capital did with TFS. Back in 2024, they snagged TFS through a carve-out and didn't just sit on it like a lazy trader watching stock tickers race by. Instead, they pushed the envelope with smart...

Continue Reading
Rachel Noble Joins AGS: Signals Strategy Shift

Updated Category News Views 92

A Tactical Addition to American Global Strategies The chessboard of global security just saw a savvy new player join American Global Strategies (AGS). Rachel Noble, a name that echoes through the halls of Australia's national security apparatus, has joined AGS as Senior Advisor. This isn't your garden-variety hire—this is a strategic power move. From Down Under to the...

Continue Reading
NHTSA, Ad Council Unveil New Anti-Buzzed Driving PSAs

Updated Category News Views 71

Taking Aim at a Deadly Habit Everyone's got that gut feeling when a day-long meeting runs over or you're stuck in traffic — impatience morphed with slow burn menace. Now picture a whole campaign gunning for that vibe but in the hands of the young folks, those from 21 to 34. That's what we're talking about here, with the Ad Council and NHTSA serving up some fresh public...

Continue Reading
OpenAssets Sets Up Shop in Abu Dhabi, Joins Hub71

Updated Category News Views 128

OpenAssets Carves a Niche in Abu Dhabi OpenAssets has just staked a claim in the Middle East by setting up its headquarters in the Abu Dhabi Global Market (ADGM). Picture this: a digital asset infrastructure provider unfurling its wings in one of the most dynamic economic landscapes—it's like watching a rookie clinch the game at the stock pit. But there's more, folks....

Continue Reading
Capital Properties Faces Leadership Challenge Amid Health News

Updated Category News Views 20

Leadership Takes an Unexpected Turn at Capital Properties When the helm of a ship faces turbulence, everyone's eyes turn to the captain. In the case of Capital Properties, Inc., their captain, Chairman, CEO and President Robert H. Eder, has hit a personal snag, diagnosed with cancer but determined to steer steady despite the storm brewing within. A Glance at Capital...

Continue Reading
Centrus Energy Welcomes Nuclear Veteran to Leadership

Updated Category News Views 71

Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...

Continue Reading

Top 5 Most Recently Viewed Articles

Rexel Reports Share Buyback Activity Over Recent Days

Updated Category News Views 136

Rexel's Recent Share Buyback Activity Rexel has officially announced its trading activity for its own shares, indicating a series of buybacks executed recently. The authorized share repurchase plan was enacted following approval from their shareholders. This initiative is part of Rexel's strategy to enhance shareholder value and manage capital efficiently. Overview of...

Continue Reading
Rocket Lab USA Investors Urged to Join Legal Action Today

Updated Category News Views 293

Important Legal Update for Rocket Lab USA Investors Rocket Lab USA, Inc. (NASDAQ: RKLB) is facing a significant legal challenge regarding its securities practices. Investors who have suffered losses are encouraged to take notice of a potential lawsuit led by the renowned Faruqi & Faruqi, LLP. This law firm is reaching out to those who have incurred losses exceeding...

Continue Reading
Navios Maritime Partners L.P. Delivers Strong Financial Growth

Updated Category News Views 134

Navios Maritime Partners Financial Results Overview Navios Maritime Partners L.P. (NYSE: NMM) has recently announced its financial results, showcasing significant growth and resilience during the second quarter and the first half of 2025. The company's revenue reached an impressive $327.6 million for Q2, totaling $631.7 million for the first half of the year, which...

Continue Reading
Exploring the Future of Electric Vehicles: 2024 Insights

Updated Category News Views 207

2024 Joint EV Trends and Outlook Forecast Report Released The Auto Care Association and MEMA Aftermarket Suppliers have collaboratively launched the 2024 Joint EV Trends and Outlook Forecast, which provides a detailed analysis of the trends shaping the electric vehicle (EV) landscape. This report aims to guide professionals in the automotive aftermarket through the...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 705

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading